Here’s Why Catalyst Pharmaceuticals, Resolute Energy, Nutanix & Two Other Stocks Are Trading Higher Today

Nutanix Inc. (NASDAQ:NTNX) stock continues its upward trend after going public last week. The stock made its debut on the exchange on September 30,  and the company had raised $238 million by selling 14.87 million shares. The IPO was well received by investors and shares more than doubled in value right after the stock started trading. Following the IPO, Maxim Group initiated coverage on the stock with a ‘Buy’ rating and a price target of $40 per share.

BioTelemetry Inc. (NASDAQ:BEAT) stock is trading 15% in the green after Lake Street reaffirmed its ‘Buy’ rating and $24 price target. In their note, Lake Street analysts cited the recent introduction of Mobile Cardiac Telemetry coverage by Anthem BlueCross BlueShield. The news is accretive to the company as it offers various services and products related to continuous monitoring of patients’ health. A total of 18 funds we track hold about $87.91 million worth of of BioTelemetry stock as of the end of June, compared to 14 funds and $60.28 million, respectively, a quarter earlier.

Acacia Communications Inc. (NASDAQ:ACIA)’s stock has gained 13% after the company provided outlook for its third quarter. The company expects its non-GAAP earnings in the range of $0.83 to $0.90 per share, up from the previous estimate of $0.64 to $0.76. Revenue is expected between $130 million and $133 million. Acacia will provide the complete results on November 10. In other news, Acacia announced an offering of approximately 4.50 million shares of its common stock, which include 1.20 million shares sold by the company and 3.30 million shares from existing stockholders. Six funds in our database amassed some $73 million worth of Acacia Communications stock, which represented 5.20% of the company’s float at the end of June.

Disclosure: none